Expression of P450 1A1l 1A2 and 2 B1l 2B2 isoenzymes in rat brain was studied by Western blotting, using polyclonal antibodies raised against hepatic P450 1A1l 1A2 and 2B1l 2B2 isoenzymes. In addition, biochemical characterizations of the catalytic activities, pen toxyresorufin O-dealkylation (PROD) and ethoxyre-sorufin O-deethylation (EROD), selective for P450 2B1l 2B2 (PROD) and P450 1A1l 1A2 (EROD), were performed with rat brain microsomes. Control rat brain microsomes did not crossreact with either of the antibodies, whereas microsomes obtained from 3-methylcholanthrene (MC)-pretreated rats revealed significant immunoreactivity with anti-P450 1A1l 1A2. Similar results were observed with phenobarbital (PB)-pretreated rats, with the brain microsomes exhibiting significant immunoreactivity with anti-P450 2B1l 2B2. The induction in the P450 isoenzymes after PB or MC pretreatment was much less in the brain in comparison to the liver. Enzymatic studies indicated that the activities of PROD and EROD were induced in brain 3—4 fold by PB and MC pretreatment, respectively, and were almost completely inhibited on in vitro addition of anti-P450 2B1l 2B2 and 1A1l 1A2. These data demonstrate the expression of P4501A1l 1A2 and 2B1l 2B2 isoenzymes in the brain and indicate that, as in liver, these isoenzymes catalyze EROD and PROD, respectively, in the rat brain.
Anandatheerthavarada, H. K., M. R. Boyd and V. Ravindranath. 1992. Characterization of a phenobarbital-inducible cytochrome P-450, NADPH-cyto-chrome P-450 reductase and reconstituted cytochrome P-450 monooxygenase system from rat brain. Biochem. J.288:483–488.
2.
Anandatheerthavarada, H. K., S. K. Shankar and V. Ravindranath. 1990. Rat brain cytochromes P450: Catalytic, immunochemicalproperties and inducibi-lity of multiple forms. Brain Res.536:339–343.
3.
Anandatheerthavarada, H. K., J. F. Williams and L. Wecker. 1993. The chronic administration of nicotine induces cytochrome P450 in rat brain. J. Neuro-chem.60:1941–1944.
4.
Bergh, A. F., and H. W. Strobel. 1992. Reconstitution of the brain mixed function oxidase system: Purification of NADPH-cytochrome P450 reductase and partial purification of cytochrome P450 from whole rat brain. J. Neurochem.59:575–581.
5.
Burke, M. D., S. Thompson, C. R. Elcombe, J. Halpert, T. Haaparanta and R. T. Mayer. 1985. Ethoxy-, pentoxy-, and benzyloxyphenoxazones and homolog-ues: A series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol.34:3337–3345.
6.
Das, M., P. K. Seth, R. Dixit, and H. Mukhtar. 1982. Arylhydrocarbon hydroxy-lase of rat brain mitochondria: Properties of, and effect of inhibitors and inducers on, enzyme activity. Arch. Biochem. Biophys.217:205–215.
7.
Das, M., P. K. Seth, and H. Mukhtar. 1981. Characterization of microsomal aryl hydrocarbon hydroxylase of rat brain. J. Pharmacol. Exp. Ther.216:156–161.
8.
Dhawan, A., D. Parmar, M. Das, and P. K. Seth. 1989. Characterization of cerebral 7-ethoxycoumarin O-deethylase: Evidence for multiplicity of cytochrome P450 in brain. Biochem. Med. Metab. Biol.41:184–192.
9.
Dhawan, A., D. Parmar, M. Das, and P. K. Seth. 1990. Cytochrome P-450 dependent monooxygenases in neuronal and glial cells: Inducibility and specificity. Biochem. Biophys. Res. Commun.170:441–447.
10.
Dhawan, A., D. Parmar, and P. K. Seth. 1994. Effect of lindane on the cytochrome P450 dependent enzymes in rat brain. Can. J. Physiol. Pharmacol.72(Supp 1):295.
11.
Farin, F. M., and C. J. Omiecinski. 1993. Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. J. Toxicol. Environ. Health40:317–335.
12.
Geng, J., and H. W. Strobel. 1995. Identification of inducible mixed function oxidase system in rat glioma C6 cell line. J. Neurochem.65:554–563.
13.
Ghersi-Egea, J. F., A. Minn, and G. Siest. 1988. Anew aspect of the protective functions of the blood brain barrier: activities of four drug-metabolising enzymes in isolated rat brain microvessels. Life Sci.42:2515–2523.
14.
Ghersi-Egea, J. F., B. Leininger-Muller, G. Suleman, G. Siest, and A. Minn. 1994. Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J. Neurochem.62:1089–1096.
15.
Gonzalez, F. J.1990. Molecular genetics of the P-450 superfamily. Pharmacol. Ther.45:1–38.
16.
Gram, T. E., L. K. Okine and R. A. Gram. 1986. The metabolism of xenobiotics by certain extrahepatic organs and its relation to toxicity. Ann. Rev. Pharmacol. Toxicol.26:259–291.
17.
Hedlund, E., A. Wyss, T. Kainu, M. Backlund, C. Köhler, M. Pelto-Huikko, J.-Å. Gustafsson, and M. Warner. 1996. Cytochrome P4502D4 in the brain: Specific neuronal regulation by clozapine and toluene. Mol. Pharmacol.50:342–350.
18.
Hodgson, A. V., T. B. White, J. W. White and H. W Strobel. 1993. Expression analysis of the mixed function oxidase system in rat brain by the polymerase chain reaction. Mol. Cell. Biochem.120:171–179.
19.
Kainu, T., J.-Å. Gustafsson, and M. Pelto-Huikko. 1995. The dioxin receptor and its nuclear translocator (Arnt) in the rat brain. Neuroreport6:2557–2560.
20.
Kalow, W., and R. F. Tyndale. 1992. Debrisoquine/sparteine monooxygenase and other P450s in brain. In Kalow, W., ed. Pharmacogenetics of drug metabolism, ed. W. Kalow, 649–656. New York: Pergamon Press.
21.
Kapitulnik, J., H. V. Gelboin, F. P. Guengerich, and D. M. Jacobwitz. 1987. Immunohistochemical localization of cytochrome P450 in brain. Neuroscience20:829–833.
22.
Kawashima, H., and H. W. Strobel. 1995a. cDNA cloning of a novel rat brain cytochrome P450 belonging to the CYP2D subfamily. Biochem. Biophys. Res. Commun.209:535–540.
23.
Kawashima, H., and H. W. Strobel. 1995b. cDNA cloning of three new forms of rat brain cytochrome P450 belonging to the the CYP4F subfamily. Biochem. Biophys. Res. Commun.217:1137–1144.
24.
Köhler, C., L. G. Ericksson, T. Hansson, M. Warner, and J.-Å. Gustafsson. 1988. Immunohistochemical localization of cytochrome P-450 in the rat brain. Neurosci. Lett.84:109–114.
25.
Liccione, J. J., and M. D. Maines. 1989. Manganese-mediated increase in the rat brain mitochondrial cytochrome P-450 and drug metabolism activity: Susceptibility of the striatum. J. Pharmacol. Exp. Ther.248:222–228.
26.
Lowry, O. H., N. J. Rosebrough, A. L. Farr and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem.193:265–275.
27.
Mesnil, M., B. Testa, and P. Jenner. 1984. Xenobiotic metabolism by brain mono-oxygenases and other cerebral enzymes. Adv. Drug. Res.13:95–207.
28.
Naslund, B. M. A., H. Glaumann, M. Warner, J.-Å. Gustafsson, and T. Hansson. 1988. Cytochrome P-450 b and c in the rat brain and pituitary gland. Mol. Pharmacol.33:31–37.
29.
Perrin, R., A. Minn, J. F. Ghersi-Egea, M. C. Grassiot, and G. Siest. 1990. Distribution of cytochrome P450 activities towards alkoxyresorufm derivatives in rat brain regions, subcellular fractions and isolated cerebral microvessels. Biochem. Pharmacol.40:2145–2151.
30.
Pohl, R. J., and J. R. Fouts. 1980. A rapid method for assaying the metabolism of 7-ethoxyresorufm by microsomal subcellular fractions. Anal. Biochem.107: 150–155.
31.
Ravindranath, V., and H. K. Anandatheerthavarada. 1989. High concentration of cytochrome P-450 linked aminopyrine N-demethylase in mouse brain and associated sex difference. Biochem. J.261:769–773.
32.
Ravindranath, V., H. K. Anandatheerthavarada, and S. J. Shankar. 1989. Xenobiotic metabolism in human bra in—presence of Cytochrome P450 and associated mono-oxygenases. Brain Res.496:331–335.
33.
Rutten, A. A. J. J. L., H. E. Falke, J. F. Catsburg, H. M. Wortelboer, B. J. Blaauboer, L. Doom, E. X R. Vanleeuwen, R. Theelen, and I. M. C. M. Rietjens. 1992. Interlaboratory comparison of microsomal ethoxyresorufm and pentoxyresorufm O-dealkylation determinations: Standardization of assay conditions. Arch. Toxicol.66:237–244.
34.
Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: A laboratory manual.Second Edition, 18.74. New York: Cold Spring Harbor Laboratory Press.
35.
Schilter, B., and C. J. Omiecinski. 1993. Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. Mol. Pharmacol.44:990–996.
36.
Shahi, G. S., N. P. Das and S. M. Moochhala. 1991. 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-inducedneurotoxicity: Partial protection against striato-nigral dopamine depletion in C57 BL/6J mice by cigarette smoke exposure and β-naphthoflavone pretreatment. Neurosci. Lett.127:247–250.
37.
Strobel, H. W., H. Kawashima, J. Geng, D. Sequeira, A. Bergh, A. V. Hodgson, H. Wang and S. Shen. 1995. Expression of multiple forms of brain cytochrome P450. Toxicol. Lett.82/83:639–643.
38.
Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl. Acad. Sci. USA76:4350–4354.
39.
Tyndale, R. F., R. Sunahara, T. Inaba, W. Kalow, F. J. Gonzalez and H. B. Niznik. 1991. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): Potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6. Mol. Pharmacol.40:63–68.
40.
Volk, B., R. P. Meyer, F. V. Lintig, B. Ibach, and R. Knoth. 1995. Localization and characterization of cytochrome P450 in the brain. In vivo and in vitro investigations on phenytoin- and phenobarbital-inducible isoforms. Toxicol. Lett.82/83:655–662.
41.
Walther, B., J. F. Ghersi-Egea, Z. Jayyosi, A. Minn, and G. Siest. 1987. Ethoxy resorufin O-deethylase in rat brain subcellular fractions. Neurosci. Lett.76: 58–62.
42.
Wang, H., H. Kawashima, and H. W. Strobel. 1996. cDNA cloning of a novel CYP3A from rat brain. Biochem. Biophys. Res. Commun.221:157–162.
43.
Warner, M., and J.-Å. Gustafsson. 1994. Effect of ethanol on cytochrome P450 in the rat brain. Proc. Natl. Acad. Sci. USA91:1019–1023.
44.
Warner, M., C. Köhler, T. Hansson, and J.-Å. Gustafsson. 1988. Regional distribution of cytochrome P-450 in the rat brain: Spectral quantitation and contribution of P-450 b,e & P-450 c,d. J. Neurochem.50:1057–1065.
45.
Waxman, D. J., and L. Azaroff. 1992. Phenobarbital induction of cytochrome P-450 gene expression. Biochem. J.281:577–592.
46.
Wyss, A., J.-Å. Gustafsson, and M. Warner. 1995. Cytochromes P450 of the 2D subfamily in rat brain. Mol. Pharmacol.47:1148–1155.
47.
Zaphiropoulos, P. G., and T. Wood. 1993. Identification of the major cytochrome P450s of subfamily 2C that are expressed in brain of female rats and in olfactory lobes of ethanol treated male rats. Biochem. Biophys. Res. Commun.193:1006–1013.
